Page 193 - Read Online

Page 20 of 23 Padarti et al. Vessel Plus 2018;2:21 I http://dx.doi.org/10.20517/2574-1209.2018.34

74. Chrzanowska-Wodnicka M, White GC, 2nd, Quilliam LA, Whitehead KJ. Small GTPase Rap1 Is Essential for Mouse Development and
Formation of Functional Vasculature. PLoS One 2015;10:e0145689.
75. Hamada K, Shimizu T, Matsui T, Tsukita S, Hakoshima T. Structural basis of the membrane-targeting and unmasking mechanisms of
the radixin FERM domain. EMBO J 2000;19:4449-62.
76. Gingras AR, Liu JJ, Ginsberg MH. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. J Cell
Biol 2012;199:39-48.
77. Brütsch R, Liebler SS, Wüstehube J, Bartol A, Herberich SE, Adam MG, Telzerow A, Augustin HG, Fischer A. Integrin cytoplasmic
domain-associated protein-1 attenuates sprouting angiogenesis. Circ Res 2010;107:592-601.
78. Fournier HN, Dupé-Manet S, Bouvard D, Luton F, Degani S, Block MR, Retta SF, Albiges-Rizo C. Nuclear translocation of integrin
cytoplasmic domain-associated protein 1 stimulates cellular proliferation. Mol Biol Cell 2005;16:1859-71.
79. Calderwood DA, Fujioka Y, de Pereda JM, García-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC, Ginsberg MH.
Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin
signaling. Proc Natl Acad Sci U S A 2003;100:2272-7.
80. Bouvard D, Aszodi A, Kostka G, Block MR, Albiges-Rizo C, Fassler R. Defective osteoblast function in ICAP-1-deficient mice.
Development 2007;134:2615-25.
81. Brunner M, Millon-Frémillon A, Chevalier G, Nakchbandi IA, Mosher D, Block MR, Albigès-Rizo C, Bouvard D. Osteoblast
mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition. J Cell Biol 2011;194:307-22.
82. Liu W, Boggon TJ. Cocrystal structure of the ICAP1 PTB domain in complex with a KRIT1 peptide. Acta Crystallogr Sect F Struct Biol
Cryst Commun 2013;69:494-8.
83. Draheim KM, Fisher OS, Boggon TJ, Calderwood DA. Cerebral cavernous malformation proteins at a glance. J Cell Sci 2014;127:701-7.
84. Stiegler AL, Zhang R, Liu W, Boggon TJ. Structural determinants for binding of sorting nexin 17 (SNX17) to the cytoplasmic adaptor
protein Krev interaction trapped 1 (KRIT1). J Biol Chem 2014;289:25362-73.
85. Uhlik MT, Temple B, Bencharit S, Kimple AJ, Siderovski DP, Johnson GL. Structural and evolutionary division of phosphotyrosine
binding (PTB) domains. J Mol Biol 2005;345:1-20.
86. Harel L, Costa B, Tcherpakov M, Zapatka M, Oberthuer A, Hansford LM, Vojvodic M, Levy Z, Chen ZY, Lee FS, Avigad S, Yaniv I,
Shi L, Eils R, Fischer M, Brors B, Kaplan DR, Fainzilber M. CCM2 mediates death signaling by the TrkA receptor tyrosine kinase.
Neuron 2009;63:585-91.
87. Costa B, Kean MJ, Ast V, Knight JD, Mett A, Levy Z, Ceccarelli DF, Badillo BG, Eils R, König R, Gingras AC, Fainzilber M. STK25
protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin. J Biol Chem 2012;287:29285-9.
88. Crose LE, Hilder TL, Sciaky N, Johnson GL. Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor
1-mediated RhoA degradation in endothelial cells. J Biol Chem 2009;284:13301-5.
89. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA,
Davis GE, Li DY. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med
2009;15:177-84.
90. Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, Zhou S, Yang J, Wright AC, Foley M, Arthur JS, Whitehead KJ,
Awad IA, Li DY, Zheng X, Kahn ML. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Nature 2016;532:122-6.
91. Draheim KM, Li X, Zhang R, Fisher OS, Villari G, Boggon TJ, Calderwood DA. CCM2-CCM3 interaction stabilizes their protein
expression and permits endothelial network formation. J Cell Biol 2015;208:987-1001.
92. Zheng X, Xu C, Smith AO, Stratman AN, Zou Z, Kleaveland B, Yuan L, Didiku C, Sen A, Liu X, Skuli N, Zaslavsky A, Chen M, Cheng L,
Davis GE, Kahn ML. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. Dev
Cell 2012;23:342-55.
93. Rosen JN, Sogah VM, Ye LY, Mably JD. ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM
pathway. Dev Biol 2013;376:74-85.
94. Ceccarelli DF, Laister RC, Mulligan VK, Kean MJ, Goudreault M, Scott IC, Derry WB, Chakrabartty A, Gingras AC, Sicheri F. CCM3/
PDCD10 heterodimerizes with germinal center kinase III (GCKIII) proteins using a mechanism analogous to CCM3 homodimerization.
J Biol Chem 2011;286:25056-64.
95. Xu X, Wang X, Zhang Y, Wang DC, Ding J. Structural basis for the unique heterodimeric assembly between cerebral cavernous
malformation 3 and germinal center kinase III. Structure 2013;21:1059-66.
96. Ding J, Wang X, Li DF, Hu Y, Zhang Y, Wang DC. Crystal structure of human programmed cell death 10 complexed with inositol-
(1,3,4,5)-tetrakisphosphate: a novel adaptor protein involved in human cerebral cavernous malformation. Biochem Biophys Res
Commun. 2010;399:587-92.
97. Voss K, Stahl S, Hogan BM, Reinders J, Schleider E, Schulte-Merker S, Felbor U. Functional analyses of human and zebrafish 18-amino
acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum Mutat 2009;30:1003-11.
98. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to
growth factors. Cell 1992;70:389-99.
99. Zheng X, Xu C, Di Lorenzo A, Kleaveland B, Zou Z, Seiler C, Chen M, Cheng L, Xiao J, He J, Pack MA, Sessa WC, Kahn ML. CCM3
signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous
malformations. J Clin Invest 2010;120:2795-804.
100. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH,